Animal models for schizophrenia: A brief overview

Biomarkers for Psychiatric Disorders

Volumn , Issue , 2009, Pages 163-184

  Furuta, Miyako ^b   Kunugi, Hiroshi ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856681117     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-79251-4_7     Document Type: Chapter

References (131)

1. Adler CM, Goldberg TE, Malhotra AK, Pickar D, Breier A (1998) Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol Psychiatr 43:811-816.
2. Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A (1999) Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatr156:1646-1649.
3. Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. Am J Psychiatr 135:1081-1084.
4. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed, American Psychiatric Association, Washington, D.C.
5. Andersen JD, Pouzet B (2004). Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine. Neuropsychopharmacology 29(6):1080-1090.
6. Bakshi VP, Geyer MA (1995) Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology122:198-201.
7. Bakshi VP, Geyer MA (1998) Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci 18:8394-8401.
8. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794.
9. Boksa P (2004) Animal models of obstetric complications in relation to schizophrenia. Brain Res Brain Res Rev 45:1-17.
10. Boksa P, El-Khodor BF (2003) Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: Possible implications for schizophrenia and other disorders. Neurosci Biobehav Rev 27:91-101.
11. Braff DL (1993) Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 19:233-259.
12. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 156: 234-258.
13. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339-343.
14. Brake WG, Noel MB, Boksa P, Gratton A (1997) Influence of perinatal factors on the nucleus accumbens dopamine response to repeated stress during adulthood: An electrochemical study in the rat. Neuroscience 77:1067-1076.
15. Brown RW, Bardo MT, Mace DD, Phillips SB, Kraemer PJ (2000) D-Amphetamine facilitation of morris water task performance is blocked by eticlopride and correlated with increased dopamine synthesis in the prefrontal cortex. Behav Brain Res 114:135-143.
16. Cannon TD, Rosso IM (2002) Levels of analysis in etiological research on schizophrenia. Dev Psychopathol 14: 653-66.
17. Clapcote SJ, Roder JC (2006) Deletion polymorphism of Disc1 is common to all 129 mouse substrains: Implications for gene-Targeting studies of brain function. Genetics; 173:2407-2410.
18. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, Roder JC (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54:387-402.
19. Coghill EL, Hugill A, Parkinson N, Davison C, Glenister P, Clements S, Hunter J, Cox RD, Brown SD (2002) A gene-driven approach to the identification of ENU mutants in the mouse. Nat Genet 30:255-256.
20. Creese I, Iversen SD (1973) Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 55:369-382.
21. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
22. Danysz W, Wroblewski JT, Costa E (1988) Learning impairment in rats by N-methyl-D-Aspartate receptor antagonists. Neuropharmacology 27:653-656.
23. Deutsch SI, Mastropaolo J, Rosse RB (1998) Neurodevelopmental consequences of early exposure to phencyclidine and related drugs. Clin Neuropharmacol 21:320-332.
24. Dunn LA, Atwater GE, Kilts CD (1993) Effects of antipsychotic drugs on latent inhibition: Sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology (Berl) 112:315-323.
25. Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH (2004) Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 153:507-519.
26. Duncan GE, Moy SS, Lieberman JA, Koller BH (2006) Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 85:481-491.
27. Duncan GE, Moy SS, Lieberman JA, Koller BH (2006) Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl) 184:190-200.
28. Eckerman DA, Gordon WA, Edwards JD, MacPhail RC, Gage MI (1980) Effects of scopolamine, pentobarbital, and amphetamine on radial arm maze performance in the rat. Pharmacol Biochem Behav12:595-602.
29. El-Khodor BF, Boksa P (1998) Birth insult increases amphetamine-induced behavioral responses in the adult rat. Neuroscience 87:893-904.
30. El-Khodor BF, Boksa P (2000) Transient birth hypoxia increases behavioral responses to repeated stress in the adult rat. Behav Brain Res 107:171-175.
31. El-Khodor B, Boksa P (2001) Caesarean section birth produces long term changes in dopamine D1 receptors and in stress-induced regulation of D3 and D4 receptors in the rat brain. Neuropsychopharmacology 25:423-439.
32. El-Khodor BF, Boksa P (2002) Birth insult and stress interact to alter dopamine transporter binding in rat brain. Neuroreport 13:201-206.
33. Ellenbroek BA, Cools AR (2002) Apomorphine susceptibility and animal models for psychopathology: Genes and environment, Behav Genet 32:349-361.
34. Ennaceur A (1994) Effects of amphetamine and medial septal lesions on acquisition and retention of radial maze learning in rats. Brain Res 636:277-285.
35. Erbel-Sieler C, Dudley C, Zhou Y, Wu X, Estill SJ, Han T, Diaz-Arrastia R, Brunskill EW, Potter SS, McKnight SL (2004) Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors. Proc Natl Acad Sci U S A 101:13648-13653.
36. Feldon J, Weiner I (1991) The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biol Psychiatr 29:635-646.
37. Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L (2005) A meta-Analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychol Rev 15:73-95.
38. Fradley RL, O'Meara GF, Newman RJ, Andrieux A, Job D, Reynolds DS (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Research163:257-264.
39. Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S (2003) Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci U S A 100: 8987-8992.
40. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: A decade in review. Psychopharmacology (Berl) 156:117-154.
41. Geyer MA, McIlwain KL, Paylor R (2002) Mouse genetic models for prepulse inhibition: An early review. Mol Psychiatr 7:1039-53.
42. Gothelf D, Soreni N, Nachman RP, Tyano S, Hiss Y, Reiner O, Weizman A (2000) Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia. Eur Neuropsychopharmacol 10:389-395.
43. Graham FK (1975) The more or less startling effects of weak prestimulation. Psychophysiology 12:238-248.
44. Gray NS, Hemsley DR, Gray JA (1992). Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol Psychiatr Brain Res 1:83-89.
45. Greengard P (2001) The neurobiology of dopamine signaling. Biosci Rep 21:247-269.
46. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatr 153:321-330.
47. Handelmann GE, Contreras PC, O'Donohue TL (1987) Selective memory impairment by phencyclidine in rats. Eur J Pharmacol 140:69-73.
48. Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, Ishimoto T, Mori T, Nemoto K, Adachi N, Izumi A, Chiba S, Noguchi H, Suzuki T, Iwata N, Ozaki N, Taguchi T, Kamiya A, Kosuga A, Tatsumi M, Kamijima K, Weinberger DR, Sawa A, Kunugi H (2006) Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 15:3024-3033.
49. Heale V, Harley C (1990) MK-801 and AP5 impair acquisition, but not retention, of the Morris milk maze. Pharmacol Biochem Behav 36:145-149.
50. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andradé M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A (2007) Dominantnegative DISC1 transgenic mice display schizophrenia-Associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A 104:14501-14506.
51. Hijzen TH, Broersen LM, Slangen JL (1991) Effects of subchronic d-Amphetamine on prepulse and gap inhibition of the acoustic startle reflex in rats. Biol Psychiatr 1119-1128.
52. Hoffman HS, Searle JL (1968) Acoustic and temporal factors in the evocation of startle. J Acoust Soc Am 43:269-282.
53. Hodgkinson CA, Goldman D, Jaeger J, Persaud S, Kane JM, Lipsky RH, Malhotra AK (2004) Disrupted in schizophrenia 1 (DISC1): Association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 75:862-872.
54. Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Omori M, Takahashi S, Tsukue R, Anami K, Hirabayashi N, Harada S, Saitoh O, Iwase M, Kajimoto O, Takeda M, Okabe S, Kunugi H (2006) Antipsychoticmedication and cognitive function in schizophrenia. Schizophr Res 86:138-146.
55. Imre G, Fokkema DS, Den Boer JA, Ter Horst GJ (2006) Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Res Bull 69:338-345.
56. Jacobs PS, Taylor BM, Bardgett ME (2000) Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK-801. Brain Res Dev Brain Res 122:91-95.
57. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatr148:1301-1308.
58. Jentsch JD, Tran A, Le D, Youngren KD, Roth RH (1997) Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal corticaldependent cognition in the rat. Neuropsychopharmacology 17:92-99.
59. Jones KW, Bauerle LM, DeNoble VJ (1990) Differential effects of sigma and phencyclidine receptor ligands on learning. Eur J Pharmacol 179: 97-102.
60. Kalivas PW, Hooks MS, Sorg B (1993) The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334.
61. Kamnasaran D, Muir WJ, Ferguson-Smith MA, Cox DW (2003) Disruption of the neuronal PAS3 gene in a family affected with schizophrenia. J Med Genet 40:325-332.
62. Karl T, Duffy L, Scimone A, Harvey RP, Schofield PR (2007) Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: Implications for understanding schizophrenia. Genes Brain Behav 6:677-687.
63. Keefe RS, Silva SG, Perkins DO, Lieberman JA (1999) The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-Analysis. Schizophr Bull 25:201-222.
64. Keefe RS, Eesley CE, Poe MP (2005) Defining a cognitive function decrement in schizophrenia. Biol Psychiatr 57:688-691.
65. Keith VA, Mansbach RS, Geyer MA (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatr 30:557-566.
66. Kesner RP, Hardy JD, Novak JM (1983) Phencyclidine and behavior: II. Active avoidance learning and radial arm maze performance. Pharmacol Biochem Behav 18:351-356.
67. Kumari V, Cotter PA, Mulligan OF, Checkley SA, Gray NS, Hemsley DR (1999) Thornton JC, Corr PJ, Toone BK, Gray JA: Effects of d-Amphetamine and haloperidol on latent inhibition in healthy male volunteers. J Psychopharmacol 13:398-405.
68. Kunugi H, Takei N, Murray RM, Saito K, Nanko S (1996) Small head circumference at birth in schizophrenia. Schizophr Res 20:165-170.
69. Kunugi H, Nanko S, Murray RM (2001) Obstetric complications and schizophrenia: Prenatal underdevelopment and subsequent neurodevelopmental impairment. Br J Psychiatr Suppl 40:25-9.
70. Kunugi H, Tanaka M, Hori H, Hashimoto R, Saitoh O, Hironaka N (2007) Prepulse inhibition of acoustic startle in Japanese patients with chronic schizophrenia. Neurosci Res 59:23-28.
71. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455-467.
72. Li Z, Kim CH, Ichikawa J, Meltzer HY (2003) Effect of repeated administration of phencyclidine on spatial performance in an eight-Arm radial maze with delay in rats and mice. Pharmacol Biochem Behav 75:335-340.
73. Lipska BK, Weinberger DR (1993) Delayed effects of neonatal hippocampal damage on haloperidolinduced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Brain Res Dev Brain Res 75:213-222.
74. Lipska BK, Weinberger DR (2000) To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology 23:223-239.
75. Lipska BK, Jaskiw GE, Weinberger DR (1993) Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75.
76. Lubow RE (1997) Latent inhibition as a measure of learned inattention: Some problems and solutions. Behav Brain Res 88:75-83.
77. Lubow RE, Gewirtz JC (1995) Latent inhibition in humans: Data, theory, and implications for schizophrenia. Psychol Bull 117:87-103.
78. Lubow RE, Moore (1959) Latent inhibition: The effect of non-reinforced preexposure to the conditioned stimulus. J Comp Physiol Psychol 52:415-419.
79. Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology 2: 299-308.
80. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94:507-514.
81. Marquis JP, Goulet S, Doré FY (2003) Schizophrenia-like syndrome inducing agent phencyclidine failed to impair memory for temporal order in rats. Neurobiol Learn Mem. 80:158-167.
82. Marquis JP, Audet MC, Doré FY, Goulet S (2007) Delayed alternation performance following subchronic phencyclidine administration in rats depends on task parameters. Prog Neuropsychopharmacol Biol Psychiatr 31:1108-1112.
83. McNeil TF, Cantor-Graae E (2000) Neuromotor markers of risk for schizophrenia. Aust N Z J Psychiatry 34:86-90.
84. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, Clair DM, Muir WJ, Blackwood DH, Porteous DJ (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9:1415-1423.
85. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron MG, Tonegawa S (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A 100:8987-8992.
86. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
87. Moghaddam B, Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349-1352.
88. Morrens M, Hulstijn W, Lewi PJ, De Hert M, Sabbe BG (2006) Stereotypy in schizophrenia. Schizophr Res 84:397-404.
89. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Meth 11:47-60.
90. Murray RM, Lewis SW (1987) Is schizophrenia a neurodevelopmental disorder? Br Med J 295:681-682.
91. Murray TK, Ridley RM (1997) The effect of dizocilpine (MK-801) on conditional discrimination learning in the rat. Behav Pharmacol 8:383-388.
92. Myhrer T (2003) Neurotransmitter systems involved in learning and memory in the rat: A meta-Analysis based on studies of four behavioral tasks. Brain Res Brain Res Rev 41: 268-287.
93. Myin-Germeys I, Delespaul P, van Os J (2005) Behavioural sensitization to daily life stress in psychosis. Psychol Med 35:733-741.
94. Noda Y, Yamada K, Furukawa H, Nabeshima T (1995) Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: A new model of schizophrenia. Br J Pharmacol 116:2531-2537.
95. Noda Y, Mamiya T, Furukawa H, Nabeshima T (1997) Effects of antidepressants on phencyclidine-induced enhancement of immobility in a forced swimming test in mice. Eur J Pharmacol 324:135-140.
96. Norton N, Williams HJ, Williams NM, Spurlock G, Zammit S, Jones G, Jones S, Owen R, O'Donovan MC, Owen MJ (2003) Mutation screening of the Homer gene family and association analysis in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 120:18-21.
97. O'Tuathaigh CM, O'Connor AM, O'Sullivan GJ, Lai D, Harvey R, Croke DT, Waddington JL (2008) Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1. Prog Neuropsychopharmacol Biol Psychiatr 32:462-466.
98. Packard MG, White NM (1989) Memory facilitation produced by dopamine agonists: Role of receptor subtype and mnemonic requirements. Pharmacol Biochem Behav 33:511-518.
99. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, Mosolov SN, Neznanov NG, Reznik AM, Smulevich AB, Tochilov VA, Johnson BG, Monn JA, Schoepp DD (2007) Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial. Nat Med 13:1102-1107.
100. Picada J.N., Henriques J.A. and Roesler R (2003) An oxidized form of apomorphine fails to induce stereotypy. Schizophr. Res 63:199-200.
101. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216.
102. Porsolt RD, Bertin A, Jalfre M (1978) 'Behavioural despair' in rats and mice: Strain differences and the effects of imipramine. Eur J Pharmacol 51:291-294.
103. Powell CM, Miyakawa T (2006) Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder? Biol Psychiatr 59:1198-1207.
104. Randrup A, Munkvad I (1974) Pharmacology and physiology of stereotyped behavior. J Psychiatr Res 11:1-10.
105. Ridley RM (1994) The psychology of perserverative and stereotyped behaviour. Prog Neurobiol 44: 221-231.
106. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157-198.
107. Sams-Dodd F (1996) Phencyclidine-induced stereotyped behaviour and social isolation in rats: A possible animal model of schizophrenia. Behav Pharmacol 7:3-23.
108. Sams-Dodd F (1998) Effects of continuous D-Amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats. Neuropsychopharmacology 19:18-25.
109. Sams-Dodd F, Lipska BK, Weinberger DR (1997) Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl) 132:303-310.
110. Sato M, Chen C-C, Akiyama K, Otsuki S (1983) Acute exacerbation of paranoid psychotic state after long-Term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatr 18:429-440.
111. Solomon PR, Crider A, Winkelman JW, Turi A, Kamer RM, Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: Relationship to schizophrenic attention disorder. Biol Psychiatr 16:519-537.
112. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, Hjaltason O, Birgisdottir B, Jonsson H, Gudnadottir VG, Gudmundsdottir E, Bjornsson A, Ingvarsson B, Ingason A, Sigfusson S, Hardardottir H, Harvey RP, Lai D, Zhou M, Brunner D, Mutel V, Gonzalo A, Lemke G, Sainz J, Johannesson G, Andresson T, Gudbjartsson D, Manolescu A, Frigge ML, Gurney ME, Kong A, Gulcher JR, Petursson H, Stefansson K (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877-892.
113. Swerdlow NR, Geyer MA (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24:285-301.
114. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatr 51:139-154.
115. Szumlinski KK, Lominac KD, Kleschen MJ, Oleson EB, Dehoff MH, Schwarz MK, Seeburg PH, Worley PF, Kalivas PW (2005) Behavioral and neurochemical phenotyping of Homer1 mutant mice: Possible relevance to schizophrenia. Genes Brain Behav 4:273-288.
116. Takao K, Yamasaki N, Miyakawa T (2007) Impact of brain-behavior phenotypying of geneticallyengineered mice on research of neuropsychiatric disorders. Neurosci Res 58:124-132.
117. Thornton AE, Van Snellenberg JX, Sepehry AA, Honer W (2006) The impact of atypical antipsychotic medications on long-Term memory dysfunction in schizophrenia spectrum disorder: A quantitative review. J. Psychopharmacol 20:335-346.
118. Ujike H (2002) Stimulant-induced psychosis and schizophrenia: The role of sensitization. Curr Psychiatr Rep 4:177-184.
119. Vaillancourt C, Boksa P (2000) Birth insult alters dopamine-mediated behavior in a precocial species, the guinea pig. Implications for schizophrenia. Neuropsychopharmacology 23:654-666.
120. Verma A, Moghaddam B (1996) NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine. J Neurosci 16:373-379.
121. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM (2001) Longterm behavioral and neurodegenerative effects of perinatal phencyclidine administration: Implications for schizophrenia. Neuroscience 107:535-550.
122. Warburton EC, Joseph MH, Feldon J, Weiner I, Gray JA (1994) Antagonism of amphetamineinduced disruption of latent inhibition in rats by haloperidol and ondansetron: Implications for a possible antipsychotic action of ondansetron. Psychopharmacology (Berl) 114: 657-664.
123. Wass C, Archer T, Pǎlsson E, Fejgin K, Klamer D, Engel JA, Svensson L (2006) Effects of phencyclidine on spatial learning and memory: Nitric oxide-dependent mechanisms. Behav Brain Res 171:147-153.
124. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatr 44:660-669.
125. Weiner I, Lubow RE, Feldon J (1984) Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology (Berl) 83:194-199.
126. Weiner I, Lubow RE, Feldon J (1988) Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30:871-878.
127. Weiner I, Shadach E, Barkai R, Feldon J (1997) Haloperidol-And clozapine-induced enhancement of latent inhibition with extended conditioning: Implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology 16:42-50.
128. Wolff MC, Leander JD (2003) Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology (Berl) 168:410-416.
129. Yuii K, Suzuki M, Kurachi M (2007) Stress sensitization in schizophrenia. Ann N Y Acad Sci 1113:276-290.
130. Zeng H, Chattarji S, Barbarosie M, Rondi-Reig L, Philpot BD, Miyakawa T, Bear MF, Tonegawa S (2001) Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107:617-629.
131. Zhang HT, Huang Y, Suvarna NU, Deng C, Crissman AM, Hopper AT, De Vivo M, Rose GM, O'Donnell JM (2005) Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-Arm maze and inhibitory avoidance tests in rats. Psychopharmacology (Berl) 179:613-619.